EMEA (Europe, Middle East and Africa) Activin Receptor Type 1 Market Report 2017

January 2018 | 101 pages | ID: ED85E807F3FEN
QYResearch

Abstracts

In this report, the EMEA Activin Receptor Type 1 market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Activin Receptor Type 1 for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Activin Receptor Type 1 market competition by top manufacturers/players, with Activin Receptor Type 1 sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Blueprint Medicines Corp
• Daiichi Sankyo Company Ltd
• La Jolla Pharmaceutical Company
• Oncodesign SA
• Tolero Pharmaceuticals Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• LJPC-6417
• TP-0184
• Dipyridamole
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Alport Syndrome
• Chronic Kidney Disease
• Kidney Fibrosis
• Obesity
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Activin Receptor Type 1 Market Report 2017

1 ACTIVIN RECEPTOR TYPE 1 OVERVIEW

1.1 Product Overview and Scope of Activin Receptor Type
1.2 Classification of Activin Receptor Type
  1.2.1 EMEA Activin Receptor Type 1 Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Activin Receptor Type 1 Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 LJPC-6417
  1.2.4 TP-0184
  1.2.5 Dipyridamole
  1.2.6 Others
1.3 EMEA Activin Receptor Type 1 Market by Application/End Users
  1.3.1 EMEA Activin Receptor Type 1 Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Alport Syndrome
  1.3.3 Chronic Kidney Disease
  1.3.4 Kidney Fibrosis
  1.3.5 Obesity
  1.3.6 Others
1.4 EMEA Activin Receptor Type 1 Market by Region
  1.4.1 EMEA Activin Receptor Type 1 Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Activin Receptor Type 1 (2012-2022)
  1.5.1 EMEA Activin Receptor Type 1 Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Activin Receptor Type 1 Revenue and Growth Rate (2012-2022)

2 EMEA ACTIVIN RECEPTOR TYPE 1 COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Activin Receptor Type 1 Market Competition by Players/Manufacturers
  2.1.1 EMEA Activin Receptor Type 1 Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Activin Receptor Type 1 Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Activin Receptor Type 1 Sale Price by Players (2012-2017)
2.2 EMEA Activin Receptor Type 1 (Volume and Value) by Type/Product Category
  2.2.1 EMEA Activin Receptor Type 1 Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Activin Receptor Type 1 Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Activin Receptor Type 1 Sale Price by Type (2012-2017)
2.3 EMEA Activin Receptor Type 1 (Volume) by Application
2.4 EMEA Activin Receptor Type 1 (Volume and Value) by Region
  2.4.1 EMEA Activin Receptor Type 1 Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Activin Receptor Type 1 Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Activin Receptor Type 1 Sales Price by Region (2012-2017)

3 EUROPE ACTIVIN RECEPTOR TYPE 1 (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Activin Receptor Type 1 Sales and Value (2012-2017)
  3.1.1 Europe Activin Receptor Type 1 Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Activin Receptor Type 1 Revenue and Growth Rate (2012-2017)
3.2 Europe Activin Receptor Type 1 Sales and Market Share by Type
3.3 Europe Activin Receptor Type 1 Sales and Market Share by Application
3.4 Europe Activin Receptor Type 1 Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Activin Receptor Type 1 Sales Volume by Countries (2012-2017)
  3.4.2 Europe Activin Receptor Type 1 Revenue by Countries (2012-2017)
  3.4.3 Germany Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  3.4.4 France Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  3.4.5 UK Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  3.4.6 Russia Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  3.4.7 Italy Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Activin Receptor Type 1 Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ACTIVIN RECEPTOR TYPE 1 (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Activin Receptor Type 1 Sales and Value (2012-2017)
  4.1.1 Middle East Activin Receptor Type 1 Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Activin Receptor Type 1 Revenue and Growth Rate (2012-2017)
4.2 Middle East Activin Receptor Type 1 Sales and Market Share by Type
4.3 Middle East Activin Receptor Type 1 Sales and Market Share by Application
4.4 Middle East Activin Receptor Type 1 Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Activin Receptor Type 1 Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Activin Receptor Type 1 Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  4.4.4 Israel Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  4.4.5 UAE Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  4.4.6 Iran Activin Receptor Type 1 Sales and Growth Rate (2012-2017)

5 AFRICA ACTIVIN RECEPTOR TYPE 1 (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Activin Receptor Type 1 Sales and Value (2012-2017)
  5.1.1 Africa Activin Receptor Type 1 Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Activin Receptor Type 1 Revenue and Growth Rate (2012-2017)
5.2 Africa Activin Receptor Type 1 Sales and Market Share by Type
5.3 Africa Activin Receptor Type 1 Sales and Market Share by Application
5.4 Africa Activin Receptor Type 1 Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Activin Receptor Type 1 Sales Volume by Countries (2012-2017)
  5.4.2 Africa Activin Receptor Type 1 Revenue by Countries (2012-2017)
  5.4.3 South Africa Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Activin Receptor Type 1 Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Activin Receptor Type 1 Sales and Growth Rate (2012-2017)

6 EMEA ACTIVIN RECEPTOR TYPE 1 MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Blueprint Medicines Corp
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Activin Receptor Type 1 Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Blueprint Medicines Corp Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Daiichi Sankyo Company Ltd
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Activin Receptor Type 1 Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 La Jolla Pharmaceutical Company
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Activin Receptor Type 1 Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Oncodesign SA
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Activin Receptor Type 1 Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Oncodesign SA Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Tolero Pharmaceuticals Inc
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Activin Receptor Type 1 Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 ACTIVIN RECEPTOR TYPE 1 MANUFACTURING COST ANALYSIS

7.1 Activin Receptor Type 1 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Activin Receptor Type

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Activin Receptor Type 1 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Activin Receptor Type 1 Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ACTIVIN RECEPTOR TYPE 1 MARKET FORECAST (2017-2022)

11.1 EMEA Activin Receptor Type 1 Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Activin Receptor Type 1 Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Activin Receptor Type 1 Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Activin Receptor Type 1 Price and Trend Forecast (2017-2022)
11.2 EMEA Activin Receptor Type 1 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Activin Receptor Type 1 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Activin Receptor Type 1 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Activin Receptor Type 1 Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Activin Receptor Type 1 Sales Forecast by Type (2017-2022)
11.7 EMEA Activin Receptor Type 1 Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Activin Receptor Type
Figure EMEA Activin Receptor Type 1 Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Activin Receptor Type 1 Sales Volume Market Share by Type (Product Category) in 2016
Figure LJPC-6417 Product Picture
Figure TP-0184 Product Picture
Figure Dipyridamole Product Picture
Figure Others Product Picture
Figure EMEA Activin Receptor Type 1 Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Activin Receptor Type 1 by Application in 2016
Figure Alport Syndrome Examples
Table Key Downstream Customer in Alport Syndrome
Figure Chronic Kidney Disease Examples
Table Key Downstream Customer in Chronic Kidney Disease
Figure Kidney Fibrosis Examples
Table Key Downstream Customer in Kidney Fibrosis
Figure Obesity Examples
Table Key Downstream Customer in Obesity
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Activin Receptor Type 1 Market Size (Million USD) by Region (2012-2022)
Figure Europe Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Activin Receptor Type 1 Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Activin Receptor Type 1 Revenue (Million USD) Status and Forecast by Countries
Figure Africa Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Activin Receptor Type 1 Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Activin Receptor Type 1 Sales Volume and Growth Rate (2012-2022)
Figure EMEA Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Activin Receptor Type 1 Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Activin Receptor Type 1 Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Activin Receptor Type 1 Sales Share by Players (2012-2017)
Figure 2016 Activin Receptor Type 1 Sales Share by Players
Figure 2017 Activin Receptor Type 1 Sales Share by Players
Figure EMEA Activin Receptor Type 1 Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Activin Receptor Type 1 Revenue (Million USD) by Players (2012-2017)
Table EMEA Activin Receptor Type 1 Revenue Share by Players (2012-2017)
Table 2016 EMEA Activin Receptor Type 1 Revenue Share by Players
Table 2017 EMEA Activin Receptor Type 1 Revenue Share by Players
Table EMEA Activin Receptor Type 1 Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Activin Receptor Type 1 Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Activin Receptor Type 1 Sales Share by Type (2012-2017)
Figure Sales Market Share of Activin Receptor Type 1 by Type (2012-2017)
Figure EMEA Activin Receptor Type 1 Sales Market Share by Type (2012-2017)
Table EMEA Activin Receptor Type 1 Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Activin Receptor Type 1 Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Activin Receptor Type 1 by Type in 2016
Table EMEA Activin Receptor Type 1 Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Activin Receptor Type 1 Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Activin Receptor Type 1 Sales Share by Application (2012-2017)
Figure Sales Market Share of Activin Receptor Type 1 by Application (2012-2017)
Figure EMEA Activin Receptor Type 1 Sales Market Share by Application in 2016
Table EMEA Activin Receptor Type 1 Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Activin Receptor Type 1 Sales Share by Region (2012-2017)
Figure Sales Market Share of Activin Receptor Type 1 by Region (2012-2017)
Figure EMEA Activin Receptor Type 1 Sales Market Share in 2016
Table EMEA Activin Receptor Type 1 Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Activin Receptor Type 1 Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Activin Receptor Type 1 by Region (2012-2017)
Figure EMEA Activin Receptor Type 1 Revenue Market Share Regions in 2016
Table EMEA Activin Receptor Type 1 Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Activin Receptor Type 1 Revenue and Growth Rate (2012-2017)
Table Europe Activin Receptor Type 1 Sales (K Pcs) by Type (2012-2017)
Table Europe Activin Receptor Type 1 Market Share by Type (2012-2017)
Figure Europe Activin Receptor Type 1 Market Share by Type in 2016
Table Europe Activin Receptor Type 1 Sales (K Pcs) by Application (2012-2017)
Table Europe Activin Receptor Type 1 Market Share by Application (2012-2017)
Figure Europe Activin Receptor Type 1 Market Share by Application in 2016
Table Europe Activin Receptor Type 1 Sales (K Pcs) by Countries (2012-2017)
Table Europe Activin Receptor Type 1 Sales Market Share by Countries (2012-2017)
Figure Europe Activin Receptor Type 1 Sales Market Share by Countries (2012-2017)
Figure Europe Activin Receptor Type 1 Sales Market Share by Countries in 2016
Table Europe Activin Receptor Type 1 Revenue (Million USD) by Countries (2012-2017)
Table Europe Activin Receptor Type 1 Revenue Market Share by Countries (2012-2017)
Figure Europe Activin Receptor Type 1 Revenue Market Share by Countries (2012-2017)
Figure Europe Activin Receptor Type 1 Revenue Market Share by Countries in 2016
Figure Germany Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Activin Receptor Type 1 Sales (K Pcs) by Type (2012-2017)
Table Middle East Activin Receptor Type 1 Market Share by Type (2012-2017)
Figure Middle East Activin Receptor Type 1 Market Share by Type (2012-2017)
Table Middle East Activin Receptor Type 1 Sales (K Pcs) by Applications (2012-2017)
Table Middle East Activin Receptor Type 1 Market Share by Applications (2012-2017)
Figure Middle East Activin Receptor Type 1 Sales Market Share by Application in 2016
Table Middle East Activin Receptor Type 1 Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Activin Receptor Type 1 Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Activin Receptor Type 1 Sales Volume Market Share by Countries in 2016
Table Middle East Activin Receptor Type 1 Revenue (Million USD) by Countries (2012-2017)
Table Middle East Activin Receptor Type 1 Revenue Market Share by Countries (2012-2017)
Figure Middle East Activin Receptor Type 1 Revenue Market Share by Countries (2012-2017)
Figure Middle East Activin Receptor Type 1 Revenue Market Share by Countries in 2016
Figure Saudi Arabia Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Activin Receptor Type 1 Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Activin Receptor Type 1 Sales (K Pcs) by Type (2012-2017)
Table Africa Activin Receptor Type 1 Sales Market Share by Type (2012-2017)
Figure Africa Activin Receptor Type 1 Sales Market Share by Type (2012-2017)
Figure Africa Activin Receptor Type 1 Sales Market Share by Type in 2016
Table Africa Activin Receptor Type 1 Sales (K Pcs) by Application (2012-2017)
Table Africa Activin Receptor Type 1 Sales Market Share by Application (2012-2017)
Figure Africa Activin Receptor Type 1 Sales Market Share by Application (2012-2017)
Table Africa Activin Receptor Type 1 Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Activin Receptor Type 1 Sales Market Share by Countries (2012-2017)
Figure Africa Activin Receptor Type 1 Sales Market Share by Countries (2012-2017)
Figure Africa Activin Receptor Type 1 Sales Market Share by Countries in 2016
Table Africa Activin Receptor Type 1 Revenue (Million USD) by Countries (2012-2017)
Table Africa Activin Receptor Type 1 Revenue Market Share by Countries (2012-2017)
Figure Africa Activin Receptor Type 1 Revenue Market Share by Countries (2012-2017)
Figure Africa Activin Receptor Type 1 Revenue Market Share by Countries in 2016
Figure South Africa Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Table Blueprint Medicines Corp Activin Receptor Type 1 Basic Information List
Table Blueprint Medicines Corp Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Blueprint Medicines Corp Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Blueprint Medicines Corp Activin Receptor Type 1 Sales Market Share in EMEA (2012-2017)
Figure Blueprint Medicines Corp Activin Receptor Type 1 Revenue Market Share in EMEA (2012-2017)
Table Daiichi Sankyo Company Ltd Activin Receptor Type 1 Basic Information List
Table Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Daiichi Sankyo Company Ltd Activin Receptor Type 1 Sales Market Share in EMEA (2012-2017)
Figure Daiichi Sankyo Company Ltd Activin Receptor Type 1 Revenue Market Share in EMEA (2012-2017)
Table La Jolla Pharmaceutical Company Activin Receptor Type 1 Basic Information List
Table La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure La Jolla Pharmaceutical Company Activin Receptor Type 1 Sales Market Share in EMEA (2012-2017)
Figure La Jolla Pharmaceutical Company Activin Receptor Type 1 Revenue Market Share in EMEA (2012-2017)
Table Oncodesign SA Activin Receptor Type 1 Basic Information List
Table Oncodesign SA Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Oncodesign SA Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Oncodesign SA Activin Receptor Type 1 Sales Market Share in EMEA (2012-2017)
Figure Oncodesign SA Activin Receptor Type 1 Revenue Market Share in EMEA (2012-2017)
Table Tolero Pharmaceuticals Inc Activin Receptor Type 1 Basic Information List
Table Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales (K Pcs) and Growth Rate (2012-2017)
Figure Tolero Pharmaceuticals Inc Activin Receptor Type 1 Sales Market Share in EMEA (2012-2017)
Figure Tolero Pharmaceuticals Inc Activin Receptor Type 1 Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Activin Receptor Type
Figure Manufacturing Process Analysis of Activin Receptor Type
Figure Activin Receptor Type 1 Industrial Chain Analysis
Table Raw Materials Sources of Activin Receptor Type 1 Major Manufacturers in 2016
Table Major Buyers of Activin Receptor Type
Table Distributors/Traders List
Figure EMEA Activin Receptor Type 1 Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Activin Receptor Type 1 Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Activin Receptor Type 1 Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Activin Receptor Type 1 Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Activin Receptor Type 1 Sales Market Share Forecast by Region (2017-2022)
Table EMEA Activin Receptor Type 1 Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Activin Receptor Type 1 Revenue Market Share Forecast by Region (2017-2022)
Table Europe Activin Receptor Type 1 Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Activin Receptor Type 1 Sales Market Share Forecast by Countries (2017-2022)
Table Europe Activin Receptor Type 1 Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Activin Receptor Type 1 Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Activin Receptor Type 1 Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Activin Receptor Type 1 Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Activin Receptor Type 1 Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Activin Receptor Type 1 Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Activin Receptor Type 1 Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Activin Receptor Type 1 Sales Market Share Forecast by Countries (2017-2022)
Table Africa Activin Receptor Type 1 Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Activin Receptor Type 1 Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Activin Receptor Type 1 Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Activin Receptor Type 1 Sales Market Share Forecast by Type (2017-2022)
Table EMEA Activin Receptor Type 1 Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Activin Receptor Type 1 Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources